Search Ontology:
ChEBI

alpha-L-Fucp-(1->3)-[alpha-D-Manp-(1->6)-[beta-D-Xylp-(1->2)]-beta-D-Manp-(1->4)-beta-D-GlcpNAc-(1->4)]-D-GlcpNAc

Term ID
CHEBI:53469
Synonyms
  • alpha-L-Fuc-(1->3)-[alpha-D-Man-(1->6)-[beta-D-Xyl-(1->2)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)]-D-GlcNAc
  • alpha-L-fucopyranosyl-(1->3)-[alpha-D-mannopyranosyl-(1->6)-[beta-D-xylopyranosyl-(1->2)]-beta-D-mannopyranosyl-(1->4)-2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->4)]-2-acetamido-2-deoxy-D-glucopyranose
  • alpha-L-fucosyl-(1->3)-[alpha-D-mannosyl-(1->6)-[beta-D-xylosyl-(1->2)]-beta-D-mannosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->4)]-N-acetyl-D-glucosamine
  • carbohydrate moiety of bromelain
  • Fuc-alpha-(1->3)-[Man-alpha-(1->6)-[Xyl-beta-(1->2)]-Man-beta-(1->4)-GlcNAc-beta-(1->4)]-GlcNAc
  • M0XF(3)
  • MUXF
Definition
A branched amino hexasaccharide consisting of a GlcNAc residue at the reducing end with a Man-α(1→6)-[Xyl-β(1→2)]-Man-β(1→4)-GlcNAc moiety attached via a β-(1→4)-linkage and a Fuc residue attached via an α-(1→3)-linkage.
References
  • glygen:G64799PD
  • glytoucan:G64799PD
  • pubmed:10529586
  • pubmed:12631291
  • pubmed:12704374
  • pubmed:12958180
  • pubmed:17375661
  • pubmed:18939728
  • pubmed:21243932
  • pubmed:21986086
  • pubmed:22205234
  • pubmed:25240757
  • pubmed:9621106
  • reaxys:11224917
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from alpha-L-Fucp-(1->3)-[alpha-D-Manp-(1->6)-[beta-D-Xylp-(1->2)]-beta-D-Manp-(1->4)-beta-D-GlcpNAc-(1->4)]-D-GlcpNAc
Phenotype where environments contain alpha-L-Fucp-(1->3)-[alpha-D-Manp-(1->6)-[beta-D-Xylp-(1->2)]-beta-D-Manp-(1->4)-beta-D-GlcpNAc-(1->4)]-D-GlcpNAc
Phenotype modified by environments containing alpha-L-Fucp-(1->3)-[alpha-D-Manp-(1->6)-[beta-D-Xylp-(1->2)]-beta-D-Manp-(1->4)-beta-D-GlcpNAc-(1->4)]-D-GlcpNAc
Phenotype affecting alpha-L-Fucp-(1->3)-[alpha-D-Manp-(1->6)-[beta-D-Xylp-(1->2)]-beta-D-Manp-(1->4)-beta-D-GlcpNAc-(1->4)]-D-GlcpNAc
Human Disease Model